Chestnut (Castanea sativa Mill. and Related Species): A Comprehensive Reference
1. Identity and Botanical Classification
Sweet chestnut (Castanea sativa Mill.) is the species most widely associated with food, nutraceutical, and medicinal applications in Europe. It is a species from the Fagaceae family, mainly found in Mediterranean Europe. The chestnut tree belongs to the genus Castanea and family Fagaceae, the same family as the oaks (Quercus) and the beeches (Fagus).
The genus Castanea includes several species of medicinal and nutritional relevance, most notably:
- Castanea sativa Mill. — European or sweet chestnut (the primary food and supplement source in Europe)
- Castanea crenata Siebold & Zucc. — Japanese chestnut
- Castanea dentata (Marshall) Borkh. — American chestnut
- Castanea mollissima Blume — Chinese chestnut
A critically important distinction applies throughout this article: Castanea species (true chestnuts, edible) must not be confused with horse chestnut (Aesculus hippocastanum L., family Sapindaceae), which is botanically unrelated, toxic in its raw state, and used for entirely different pharmacological purposes. Do not confuse horse chestnut with sweet chestnuts: sweet chestnuts belong to a different plant species and are non-toxic. Because horse chestnut is among the most intensively studied botanical dietary supplements, and because the shared common name "chestnut" creates significant confusion in the literature and in commerce, this article addresses both in separate sections where relevant. However, the primary focus is on Castanea sativa and the edible chestnut genus.
1a. Common Names and Synonyms
- Castanea sativa: sweet chestnut, European chestnut, Spanish chestnut, marron (French), castagna (Italian), Esskastanie (German)
- Aesculus hippocastanum: horse chestnut, conker tree; seed extract is marketed under trade names including Venostasin, Aesculaforce, and Venastat; aescin (aescuforce), HCSE, hippocastani semen, marronier, and rosskastanie are among its designations in various pharmacopeias and markets.
1b. Plant Parts Used
For Castanea sativa, multiple plant parts are studied or used:
- Fruit (nut kernel): primary food use; dried, roasted, boiled, milled into flour
- Leaves: used in traditional medicine and as a source of ellagitannins for research and cosmeceutical applications
- Inner and outer shell (pellicle and pericarp): studied as agricultural by-products rich in polyphenols and vitamin E
- Spiny bur (cupule): studied for anti-inflammatory and antioxidant compounds
- Bark and wood: traditional source of tannins
For Aesculus hippocastanum: the seed extract (HCSE) contains escin, a triterpenic saponin, as its active component. Horse chestnut is used mostly as a seed extract; for oral ingestion, tablets and tinctures are available; suppositories are used against hemorrhoids; and externally, liquid extracts can be applied as gels, ointments, or lotions.
1c. Common Supplement Forms
Castanea sativa fruit-based preparations include fresh or roasted nuts, dried flour, aqueous or hydroalcoholic extracts, chestnut leaf hydroalcoholic extracts, and standardized shell or bur extracts standardized for polyphenol or ellagitannin content. Aesculus hippocastanum supplements are standardized seed extracts, most commonly in capsule form, standardized to a defined percentage of escin/aescin.
2. Historical and Traditional Use
2a. European Traditions (Castanea sativa)
Castanea sativa Mill. is a Mediterranean staple food valued for its cultural heritage, gastronomic identity, nutritional profile, bioactivities, and socio-economic and environmental relevance. In some regions of Europe, mainly in the Mediterranean area, chestnuts are known as the "bread-tree," because they provided basic food with nutritious and health-giving properties for people.
While sweet chestnut fruits have long been used as a food both for humans and animals, the medicinal value of the tree was also understood in classical times. Dioscorides identified its astringent and tonic characteristics. Chestnut flower honey was appreciated by the Romans for its pleasant and mildly bitter taste, and was also used for dressing wounds, burns, and skin ulcers.
Culpeper recommended dried powdered peeled sweet chestnuts in honey for a cough. In some places, chestnut leaves are used as a popular remedy in fever and ague, for their tonic and astringent properties. The leaves, picked in June and July when they are in best condition, were dried or used in the fresh state medicinally.
The use of different parts of the C. sativa plant in folk medicine has long been documented, including treatment of cough, diarrhea, and infertility.
2b. Traditional Chinese Medicine (TCM)
In Traditional Chinese Medicine (TCM), chestnuts are considered good for tonifying the Kidney and supporting digestion. TCM regards chestnuts as "fruit for the kidneys" and good for treating patients with renal diseases. In winter, roasted chestnut stands can be found all over the streets of Beijing and other cities in China, where they are a popular nutritious winter snack famous for their ability to warm the lower body, especially the lower back, knees, and extremities. The Chinese also ground the nuts up and applied the mash to external cuts and wounds to help stop bleeding.
2c. Native American Traditions (Castanea dentata)
Teas were made from the leaves to remedy typhoid and stomach pains. Year-old leaves were specifically used to make tea for heart trouble, while leaves of young sprouts were used to cure old sores by dipping in hot water and applying. The Mohegans used chestnut for medicinal purposes, including using an infusion of the leaves for rheumatism, colds, and whooping cough.
2d. Horse Chestnut (Aesculus hippocastanum) Historical Use
Horse chestnut, a tree native to the Balkan Peninsula, has been used in traditional medicine for centuries. The seed extract is used as a dietary supplement to support vascular function. Traditional Chinese herbalists use horse chestnut not only for treatment of circulatory problems, but also as an astringent, a diuretic, for reduction of oedema or swelling, to reduce inflammation, as an expectorant in respiratory problems, and to fight viruses. Horse chestnut extract is used for the treatment of symptoms of varicose veins, hemorrhoids, and phlebitis; extracts of the horse chestnut seeds are also used for diarrhea, fever, and urinary hesitancy.
3. Key Constituents and Active Compounds
3a. Castanea sativa — Nutritional Composition
The chestnut fruit is well-known for its nutritional properties, namely its high concentration of carbohydrates (starch) and its low-fat content, as well as being one of the few fruits that do not contain gluten. On a dry-matter basis, the main components of the chestnut are carbohydrates (75–91%), most notably starch (39–82%), followed by sucrose.
Studies on chestnuts' chemical and nutritional composition confirm that this fruit is low in fat, cholesterol-free, and gluten-free. It is a rich source of starch (carbohydrates), protein, dietary fiber, vitamins, minerals (such as potassium, phosphorous, and magnesium), lipids, and nutrients. Furthermore, it is a good source of antioxidants such as L-ascorbic acid, carotenoids, and phenolic compounds such as gallic and ellagic acids.
Chestnuts are excellent dietary sources of carbohydrates, fiber, starch, fatty acids, minerals (mainly potassium, phosphorus, calcium, and magnesium), and vitamins (B9, C, and E).
3b. Castanea sativa — Phytochemical Composition
The diversity of phytochemicals in Castanea sativa—particularly phenolic acids, flavonoids, and ellagitannins (e.g., castalagin and vescalagin)—underpin antioxidant, anti-inflammatory, antimicrobial, anti-proliferative, and metabolic effects demonstrated across in vitro, cellular, and in vivo models.
The bark and leaves yield the richest tannin fractions. LC-MS analysis of chestnut leaf extracts has confirmed the presence of quercetin glycosides, kaempferol glycosides (i.e., astragalin), gallotannins (chestanin and chesnatin), and ellagitannins (HHDP acid, castalagin, and vescalagin).
In by-products, the inner shell presents four compounds (three flavonol glycoside derivatives and a phenolic acid), the outer shell reveals two compounds (one phenolic acid and one flavonol glycoside derivative), the bur presents six compounds (five flavonol glycoside derivatives and an ellagitannin), and the leaves yield nine compounds (eight flavonol glycoside derivatives and an ellagitannin).
Gallic acid, myricetin-3-O-glucoside, quercetin-3-O-rutinoside, quercetin-3-O-glucoside, ellagic acid, kaempferol-3-O-rutinoside, isorhamnetin-3-O-rutinoside, and quercetin-3-O-rhamnoside have been positively identified across chestnut fractions.
High levels of polyphenols are found in hydroalcoholic extracts from chestnut leaves. Among polyphenols, the ellagitannin isomers castalagin and vescalagin (about 1% w/w of dry extract) have been identified as potential bioactive compounds.
The shells are notably rich in micronutrients: shells contain carbohydrates (up to 74%), starch (64%), cellulose (19%), lignin (above 30%), vitamin E (up to 963 mg/100 g DW), polyphenols (up to 5.2%), and minerals (up to 7219 µg/g).
Using UPLC-MS/MS techniques, phytochemical investigation of chestnut spiny burr aqueous extract identified 56 metabolites, confirming the presence of phenolic compounds.
3c. Aesculus hippocastanum — Key Constituents and Mechanism of Action
The seed extract of Aesculus hippocastanum L. (HCSE) contains escin, a triterpenic saponin, as its active component. Escin has been shown to inhibit the activity of hyaluronidase, an enzyme involved in proteoglycan degradation.
Escin is a sodium salt of saponin with the molecular formula C₅₅H₈₆O₂₄. It belongs to the saponin class of compounds, which are composed of saponin and sugar chains and have a complex glycoside structure. Escin is extracted from the dried mature seeds of the horse chestnut tree (Aesculus hippocastanum).
Protoescigenin and barringtogenol are the main sapogenins and their fraction has been named escin. The main isomers are β-escin (the main constituent of the pharmaceutical preparations) and kryptoescin (less active). β-escin is relatively water-insoluble while kryptoescin is readily water-soluble.
Beyond hyaluronidase inhibition, studies have confirmed that Aesculus hippocastanum extracts and pure escin have various activities, including anti-inflammatory, antibacterial, antifungal, antiviral, antiangiogenic (vascular protection), anti-obesity, antioxidative, antidiabetic, hepatoprotective, anticoagulant, antihematoma, antigenotoxic, anti-infertility, and cytotoxic properties.
The extract from horse chestnut seeds, standardised for the content of aescin, is used as a treatment for chronic venous insufficiency. It has anti-inflammatory and anti-oedematous properties and indicates a positive effect on the venous tone, rheological properties, and blood coagulability.
Regarding bradykinin pathway effects: escin is used to treat several clinical conditions, including venous insufficiency, pain, inflammation, and edema. Inhibition of the bradykinin pathway represents a particular pharmacodynamic effect, decreasing local edema and conferring an advantage in comparison to other compounds.
Regarding anticancer mechanisms in laboratory studies: lab studies suggest that aescin/escin in horse chestnut has anti-inflammatory, neuroprotective, and antitumor effects, and may enhance gemcitabine efficacy. These findings are from in vitro and animal models only, and no clinical oncology use has been established.
4. Scientific Evidence by Area of Use
4a. Chronic Venous Insufficiency (CVI) — Horse Chestnut (Aesculus hippocastanum)
This is the area with the strongest clinical evidence for any preparation labeled "chestnut" in the supplement literature. A seed extract of horse chestnut (Aesculus hippocastanum L.) is a herbal remedy used for venous insufficiency. Seventeen randomised controlled trials were included in a Cochrane review. In all trials, the extract was standardised to escin, the main active constituent. Overall, the trials suggested an improvement in the symptoms of leg pain, oedema, and pruritus with horse chestnut seed extract when taken as capsules over two to 16 weeks.
Six placebo-controlled studies (543 participants) reported a clear reduction of leg pain when the herbal extract was compared with placebo. Similar results were reported for oedema, leg volume, leg circumference, and pruritus.
The clinical evidence is further characterized in a criteria-based systematic review: these data imply that HCSE is superior to placebo and as effective as reference medications in alleviating the objective signs and subjective symptoms of CVI, and thus represents a treatment option for CVI that is worth considering.
The evidence implies that HCSE is an efficacious and safe short-term treatment for CVI. However, several caveats exist and more rigorous RCTs are required to assess the efficacy of this treatment option.
The mechanism of HCSE/aescin activity was proposed on the basis of in vitro and in vivo studies, and its effectiveness was documented with numerous randomised clinical trials. The results have proven that horse chestnut seed extract not only significantly improves subjective symptoms in patients with CVI such as calf spasm, leg pain, pruritus, and fatigue, but it also reduced leg volume, and the ankle and calf circumference.
Evidence strength for CVI: Moderate to good. Multiple RCTs, systematic reviews, and a Cochrane review support short-term benefit. Limitations include relatively small sample sizes in individual trials and limited long-term data. More controlled clinical trials are needed, which should include larger numbers of participants and assess HCSE particularly for long-term use and as an adjunct to compression treatment.
4b. Antioxidant Activity (Castanea sativa)
The phenolic, tannin, and flavonoid content of methanol extracts of Castanea sativa burs, leaves, and chestnuts, as well as their antioxidant activity, have been evaluated by spectrophotometric methods (DPPH, TEAC, and FRAP). In vivo and in vitro studies confirm their antioxidant activity, ability to reduce oxidative stress, and potential to modulate inflammation and metabolic parameters.
The bioactivity and phytochemical composition of chestnut shells proposes innovative uses for this biowaste considering its wealth in macronutrients and micronutrients that provide health-promoting benefits, including antioxidant and anti-inflammatory effects. A recent study validated a new nutraceutical ingredient extracted from chestnut shells by proving the in-vivo antioxidant efficacy on rats orally treated with 50 and 100 mg/kg body weight and correlating it with metabolomic profiling of blood serum.
Evidence strength: Preliminary; largely in vitro and animal-model data. No human clinical trials specifically measuring antioxidant endpoints for chestnut (Castanea) supplementation have been identified in the peer-reviewed literature as of the most recent searches.
4c. Anti-Inflammatory Activity (Castanea sativa)
In vitro assays have evaluated the ability of Castanea sativa extracts to reduce NF-κB activation and nitric oxide (NO) production. Chestnut spiny burr aqueous extracts significantly downregulated pro-inflammatory mediators in LPS-stimulated RAW 264.7 macrophage cells without significant cell toxicity.
In the context of acne and skin inflammation, the effect of C. sativa leaf extract and castalagin on human keratinocytes infected with C. acnes found that both inhibited IL-8 and IL-6 release at concentrations below 25 μg/mL. The action mechanism was linked to NF-κB inhibition, without AP-1 involvement. Furthermore, the extract displayed anti-biofilm properties and reduced CK-10 expression, indicating a potential role in mitigating inflammation, bacterial colonization, and keratosis.
Evidence strength: Preliminary; in vitro and cell-line studies only. No human trials have confirmed anti-inflammatory outcomes for oral Castanea sativa supplementation.
4d. Antimicrobial Activity (Castanea sativa)
Ellagitannins have been documented for antibacterial and anti-inflammatory activities, suggesting their potential use in gastritis. Several authors have demonstrated that tannin-rich extracts from chestnut byproducts display promising biological activities.
In the context of H. pylori: in GES-1 cells infected by H. pylori, leaf extract and pure ellagitannins inhibited IL-8 release (IC₅₀ ≈ 28 µg/mL and 11 µM, respectively).
Regarding multiresistant bacteria, chestnut fractions including the inner shell, outer shell, bur, and leaves have demonstrated antioxidant and antimicrobial activity against multiresistant bacteria in laboratory settings, though all such results are from in vitro work only.
Evidence strength: Preliminary; in vitro only. No human clinical trials on chestnut (Castanea) as an antimicrobial agent have been identified.
4e. Metabolic Effects — Adiposity and Cholesterol (Castanea sativa)
Chestnut supplementation at 1.1% reduced abdominal adipose tissue in mice. Lower serum cholesterol was also observed in animals supplemented with chestnut. There were no significant differences concerning the incidence of histological lesions nor in biochemical markers of hepatic damage and oxidative stress.
FVB/n mice fed a diet enriched with chestnut fruit (1.1%) showed reduced abdominal fat without signs of oxidative or DNA damage, suggesting an improvement in energy metabolism and adiposity that may indirectly minimize insulin resistance.
The combination of hypolipidemic, hypoglycemic, antioxidant, and enzyme-modulating activities highlights the potential of Castanea sativa fruit and its by-products as valuable functional ingredients and as a source of nutraceuticals targeting metabolic health.
Spiny burrs extract of sweet chestnut improved liver and kidney function in diabetic Wistar rats, by reducing oxidative damage towards lipids and DNA and inhibiting protein glycation.
None of the previous animal studies addressed the effects of chestnut kernels in the diet in a way that fully reproduces the values of chestnuts consumed by humans.
Evidence strength: Preliminary; animal studies only. No human clinical trials have tested chestnut fruit supplementation for metabolic effects (adiposity, cholesterol) as of the available literature.
4f. Gastrointestinal Health (Castanea sativa — Traditional Use with Emerging Preclinical Data)
The high fiber and resistant starch content of chestnut fruits supports a plausible role in gastrointestinal health, consistent with the established nutritional science of dietary fiber. The use of different parts of C. sativa in folk medicine has long been documented, including treatment of cough, diarrhea, and infertility. The anti-H. pylori effects of leaf ellagitannins (as described above in section 4d) add preclinical context, but no human GI trials have been conducted.
4g. Neuroprotective Effects — Escin (Horse Chestnut)
Lab studies suggest that aescin in horse chestnut has anti-inflammatory, neuroprotective, and antitumor effects. These findings derive from cell-based and animal studies. No clinical trials have confirmed neuroprotective benefits of horse chestnut or escin in humans.
5. Body Systems and Health Areas Associated with Chestnut
- Cardiovascular and venous system: Horse chestnut (HCSE/escin) — the best-supported clinical application; chronic venous insufficiency management, varicose vein symptom relief.
- Metabolic health (glycemic and lipid regulation): Castanea sativa — preclinical (animal) evidence for adiposity reduction and cholesterol lowering.
- Gastrointestinal system: Traditional use for diarrhea and cough; preclinical antimicrobial activity against H. pylori.
- Skin and dermatology: Topical and cosmeceutical applications using leaf and bur extracts; in vitro anti-acne evidence via NF-κB inhibition.
- Renal and urinary system: Traditional TCM use for kidney tonification; no clinical substantiation.
- Musculoskeletal system: Traditional use for rheumatism (leaf infusions in Native American and European practices); not substantiated by clinical trials.
- Anti-infective potential: In vitro antimicrobial activity against multiresistant bacteria and C. acnes.
- Respiratory: Traditional use of sweet chestnut for cough (Culpeper); the sweet chestnut is a medium to large-sized medicinal tree traditionally used in respiratory complaints.
6. Dosage Forms and Dosages Reported in Studies
6a. Castanea sativa (Sweet Chestnut) — Dosages in Research
- Animal dietary supplementation: Chestnut supplementation at 1.1% (of diet mass) was used in the mouse adiposity study.
- In vitro leaf extract studies: The leaf extract inhibited IL-8 and IL-6 induced by C. acnes in a concentration-dependent fashion, with IC₅₀ values of 18.37 and 22.54 μg/mL, respectively.
- In vitro H. pylori studies: Leaf extract and pure ellagitannins inhibited IL-8 release (IC₅₀ ≈ 28 µg/mL and 11 µM, respectively).
- Animal shell extract studies: In-vivo antioxidant efficacy was demonstrated on rats orally treated with 50 and 100 mg/kg body weight.
No established human clinical dosage for Castanea sativa extracts as dietary supplements has been defined in the peer-reviewed literature, because clinical trials in humans are lacking as of the available evidence base.
6b. Aesculus hippocastanum (Horse Chestnut Seed Extract / HCSE) — Dosages in Studies
- Most commonly studied oral dose: In clinical studies, a daily dose of 600 mg of HCSE (which corresponds to 100 mg of aescin/day) was administered most frequently, mainly in two doses; patients took the medicine for 2–16 weeks.
- Typical standardization: Extracts are standardized to escin content. In all trials, the extract was standardised to escin, which is the main active constituent of horse chestnut seed extract.
- Tablet/suppository forms: Horse chestnut is used mostly as a seed extract; for oral ingestion, tablets and tinctures are available; suppositories are used against hemorrhoids; and externally, liquid extracts can be applied as gels, ointments, or lotions.
7. Safety Considerations and Drug Interactions
7a. Castanea sativa (Sweet Chestnut) — Safety
Sweet chestnuts belong to a different plant species from horse chestnut and are non-toxic. The edible fruit of Castanea sativa has a long history of safe use as a food. In the main mouse dietary supplementation study, there were no significant differences concerning the incidence of histological lesions nor in biochemical markers of hepatic damage and oxidative stress. Allergy to tree nuts may extend to chestnut in sensitive individuals; however, specific safety data from controlled human trials for Castanea sativa extracts used as supplements (i.e., at doses above typical food intake) are not available in the current literature.
7b. Aesculus hippocastanum (Horse Chestnut) — Safety
Raw seed toxicity: All parts of plants in the Aesculus family are potentially toxic, especially the seeds (nuts); horse chestnut has been classified by the Food and Drug Administration (FDA) as an unsafe herb in its raw, unprocessed form. Dietary supplements made from horse chestnut usually contain an extract of horse chestnut seed; this extract has been processed to remove a harmful chemical that is naturally found in the seed.
Liver toxicity: Despite widespread use, there have been few published instances of liver injury due to horse chestnut. In isolated cases of liver toxicity attributed to horse chestnut extracts, injury became apparent between 4 and 8 weeks after starting the herbal and were associated with either hepatocellular or mixed patterns of serum enzyme elevations with a self-limited, rapidly resolving course. The LiverTox likelihood score is rated D (possible, rare cause of clinically apparent liver injury). The cause of liver injury is likely idiosyncratic. Liver injury attributed to horse chestnut use has been relatively mild and self-limited.
Common adverse effects: Most discussions of adverse effects describe mainly mild GI upset, headache, dizziness, or itching — yet responsible health content should acknowledge rare but documented liver concerns.
Anticoagulant interactions: American ginseng and horse chestnut seed both increase anticoagulation (Use Caution/Monitor). Antithrombin alfa and horse chestnut seed both increase anticoagulation (Modify Therapy/Monitor Closely). Since horse chestnut contains active principles that may interfere with normal blood clotting, patients with bleeding disorders or those taking aspirin or warfarin should exercise caution before using this herb.
CYP450 enzyme interactions: In animal studies, aescin both inhibited and induced CYP1A2, 2C9, and 3A4, and may affect the intracellular concentration of drugs metabolized by these enzymes. Clinical relevance has yet to be determined.
Duration of studied use: Trials used HCSE taken as capsules over two to 16 weeks. Safety data beyond this duration are limited.
Contraindications: There is limited evidence of direct kidney toxicity at standard doses; however, those with pre-existing kidney disease should exercise caution, as aescin is partially excreted renally. High doses are theoretically problematic for impaired kidneys.
Regulatory note: Since April 2014, all herbal medicines for sale in the UK and Europe must be approved by the Medicines & Healthcare Products Regulatory Agency (MHRA) having been rigorously checked for safety and quality, and must display the Traditional Herbal Registration 'THR' logo on their pack. Registered herbal medicinal products containing horse chestnut are used for relieving the symptoms of varicose veins, based on traditional use only.
8. Summary of Evidence Strength
- Horse chestnut seed extract (HCSE) / escin for chronic venous insufficiency: Moderate clinical evidence. Multiple RCTs and a Cochrane review support short-term symptomatic benefit. Limitations include small sample sizes and limited long-term data.
- Castanea sativa fruit for metabolic/adiposity effects: Preliminary; animal data only.
- Castanea sativa leaf and by-product extracts for anti-inflammatory/antimicrobial effects: Preliminary; in vitro and cell-line models only.
- Traditional uses across all species: Ethnobotanically documented but not evaluated in controlled human trials.
References
Go back